Nektar
“Underwhelming” drug data devastates Nektar, shares fall by 42%
June 5, 2018Manufacturing and Production, Research and Development ASCO, BMS, Bristol-Myers Squibb, Cancer, Nektar, bristol myers-squibb, pharma
Nektar Therapeutics has seen its share price devastated after revealing disappointing trial data for its candidate NKTR-214 in combination with …
Rapidly-growing Nektar Therapeutics reportedly considering sale of its business
February 5, 2018Manufacturing and Production, Sales and Marketing M&A, MA, Nektar, Nektar Therapeutics, acquisition, pharma
After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …
Lilly snaps up autoimmune drug in $400m biotech partnership
July 25, 2017Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Nektar, aceutical, biotech, drugs, healthcare, phar, pharma
Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …
AZ strikes drug development deal with Nektar Therapeutics
September 22, 2009Research and Development AZ, Nektar
AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
